Dr. Stephen Hahn, a hospital executive and cancer specialist, is President Trump's choice for FDA commissioner, said the White House. Hahn had been rumored for the post for weeks. But in a surprise, Health Secretary Alex Azar said FDA's interim leader, Ned Sharpless, would return immediately to his previous post of director of the National Cancer Institute because he had hit a statutory time limit of 210 days for service as an acting agency chief.
If a new Food and Drug Administration draft guidance is implemented, food recall notices could begin to include the names of retailers that have sold the contaminated foods, the agency said Wednesday.
Scott Gottlieb, commissioner of the Food and Drug Administration, announced a multiyear nutrition strategy Thursday that pursues many Obama-era nutrition goals.
Scott Gottlieb, a deputy FDA commissioner during the George W. Bush era, will assume the top job in the agency following a 57-42 confirmation vote in the Senate that broke mostly along party lines. Republicans, who provided all but six six of the votes for Gottlieb, said the physician and political conservative will bring the steady hand of experience to an agency with responsibilities ranging from testing medical devices to assuring the safety of a large part of the U.S. food supply.
President Trump's nominee for FDA commissioner, Scott Gottlieb, says he might delay the debut of the updated Nutrition Facts label, now set for July 2018. For the first time, the label would list how many grams of sugar are added to foods during processing, said Food Navigator. Kansas Sen. Pat Roberts asked Gottlieb to consider a delay on grounds FDA has not finalized its "guidance" documents on dietary fiber and added sugar.
President Trump selected a physician and political conservative, Scott Gottlieb, to become commissioner of the Food and Drug Administration, the White House announced. If confirmed, he will succeed Robert Califf, who held the job for the final 11 months of the Obama administration. Gottlieb was deputy FDA commissioner for medical and scientific affairs during the second term of President George W. Bush.